OrbiMed’s Synlogic SYBX Stock Holding History

OrbiMed’s Portfolio SYBX Stock Details SYBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-401,998	Closed	-$1.13M	–	130
2023 Q3	$1.13M	Sell	401,998 -2	-0%	-$14	0.02%	119
2023 Q2	$2.59M	Hold	402,000	–	–	0.05%	111
2023 Q1	$3.81M	Hold	402,000	–	–	0.07%	108
2022 Q4	$4.58M	Hold	402,000	–	–	0.09%	96
2022 Q3	$5.73M	Hold	402,000	–	–	0.11%	102
2022 Q2	$6.93M	Hold	402,000	–	–	0.13%	103
2022 Q1	$14.5M	Hold	402,000	–	–	0.23%	82
2021 Q4	$14.6M	Hold	402,000	–	–	0.19%	100
2021 Q3	$18.4M	Buy	402,000 +155,556	+63%	+$7.27M	0.2%	100
2021 Q2	$14.4M	Buy	246,444 +111,111	+82%	+$6.07M	0.15%	110
2021 Q1	$7.27M	Hold	135,333	–	–	0.07%	131
2020 Q4	$4.38M	Hold	135,333	–	–	0.04%	141
2020 Q3	$4.1M	Hold	135,333	–	–	0.05%	130
2020 Q2	$4.12M	Hold	135,333	–	–	0.06%	123
2020 Q1	$3.49M	Hold	135,333	–	–	0.06%	114
2019 Q4	$5.24M	Hold	135,333	–	–	0.07%	104
2019 Q3	$4.65M	Hold	135,333	–	–	0.09%	96
2019 Q2	$18.5M	Hold	135,333	–	–	0.29%	73
2019 Q1	$15.4M	Hold	135,333	–	–	0.24%	83
2018 Q4	$14.2M	Hold	135,333	–	–	0.26%	78
2018 Q3	$28.8M	Hold	135,333	–	–	0.35%	75
2018 Q2	$20M	Hold	135,333	–	–	0.24%	92
2018 Q1	$19M	Buy	135,333 +47,667	+54%	+$7.39M	0.24%	83
2017 Q4	$12.8M	Hold	87,666	–	–	0.16%	98
2017 Q3	$25M	Buy	+87,666	New	+$17.9M	0.24%	79

Other funds holding SYBX

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HCA

Harbor Capital Advisors Chicago, Illinois $1.47B AUM 42.58% 1-Year Est. Return

Fiduciary Trust Boston, Massachusetts $9.19B AUM 25.65% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

OrbiMed's SYBX Position: Q4 2023 in Review

OrbiMed sold out of Synlogic (SYBX) in Q4 2023, closing a stake of 401,998 shares — an estimated $1.13M sold.

OrbiMed first reported a position in SYBX in Q3 2017 and held it in 25 quarters. The position peaked at $28.8M in Q3 2018. 24 funds tracked by Wall St. Rank hold SYBX as of Q4 2023.

OrbiMed reported no remaining Synlogic position as of Q4 2023 after selling out during the quarter.
OrbiMed sold 401,998 Synlogic shares in Q4 2023, an estimated $1.13M.
OrbiMed first reported a position in Synlogic in Q3 2017 and held it in 25 quarters.
OrbiMed's Synlogic position peaked at $28.8M in Q3 2018.
24 funds tracked by Wall St. Rank held Synlogic as of Q4 2023.

Based on OrbiMed's 13F filing for Q4 2023, filed 14 Feb 2024.